Feature Channels: Men's Health

Filters close
Newswise: American Cancer Society Releases Latest Cancer Statistics, Launches Initiative to Address Prostate Cancer Resurgence and Disparities
9-Jan-2023 2:25 PM EST
American Cancer Society Releases Latest Cancer Statistics, Launches Initiative to Address Prostate Cancer Resurgence and Disparities
American Cancer Society (ACS)

Today, the American Cancer Society released Cancer Statistics, 2023, the organization’s annual report on cancer facts and trends. According to the report, overall cancer mortality has dropped 33% since 1991, averting an estimated 3.8 million cancer deaths. Based on ACS data, in 2023 there are projected to be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States.

Released: 10-Jan-2023 2:30 PM EST
Less than four in 100 men accepted to be sperm donors
University of Sheffield

Less than four in 100 men who apply to be sperm donors reach the end of the process and have samples frozen and released for treatments, according to a new study.

Released: 10-Jan-2023 9:55 AM EST
New hormonal agent may slow progression of early-stage prostate cancer during active surveillance
Wolters Kluwer Health: Lippincott

For men with early-stage prostate cancer being managed by active surveillance, adding the hormonal agent apalutamide may lower the rate of positive biopsies during follow-up, suggests a preliminary clinical trial in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 9-Jan-2023 5:10 PM EST
Research helps explain why obesity is more dangerous for men
York University

A newly published study from York University sheds light on the biological underpinnings in sex differences in obesity-related disease, with researchers observing “striking” differences in the cells that build blood vessels in the fatty tissue of male versus female mice.

Released: 6-Jan-2023 6:05 PM EST
Tip Sheet: New genetic risk factors identified for colorectal cancer, new challenge trial on a tuberculosis vaccine — and 2022 news highlights
Fred Hutchinson Cancer Center

Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news. Interested in news you may have missed in 2022 from Fred Hutch?

Released: 6-Jan-2023 11:05 AM EST
After 40 Years of Decline, Stroke Death Rates Are Rising Again
Rutgers University-New Brunswick

Millennials face a greater risk of ischemic stroke death than Generation X, according to a Rutgers study.

Released: 4-Jan-2023 7:40 PM EST
Does COVID change the body’s response to other threats? Depends on your sex
Yale University

The long-term effects of infection on the immune system have long intrigued John Tsang, a Yale immunobiologist. After the body has faced down a pathogen, does the immune system return to the previous baseline? Or does a single infection change it in ways that alter how it will respond not only to a familiar virus but also to the next new viral or bacterial threat it faces?

Newswise: Study Finds Providers Use Prostate Cancer Screening Tests, Even When They Provide Little Value to Patients
Released: 4-Jan-2023 1:10 PM EST
Study Finds Providers Use Prostate Cancer Screening Tests, Even When They Provide Little Value to Patients
Wake Forest University School of Medicine

Prostate cancer is the second-leading cause of cancer death in men with more than 34,000 deaths in the U.S. each year, according to the American Cancer Society. But guidelines for prostate cancer screening are continually shifting, leading to uncertainty among patients and providers on when and if screening tests should be ordered. In a new study from Wake Forest University School of Medicine, researchers recently examined prostate screening testing among primary care providers and found that the tests are frequently used, even when they provide little value to patients.

Not for public release

This news release is embargoed until 2-Jan-2023 5:00 PM EST Released to reporters: 27-Dec-2022 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 2-Jan-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Model explains how autism arises
Released: 29-Dec-2022 2:10 PM EST
Model explains how autism arises
University of Gothenburg

The development of autism may now become easier to understand, thanks to an explanatory model presented in a thesis from University of Gothenburg, Sweden.

Newswise: UTSW researchers map activity of inherited gene variants linked to prostate cancer
Released: 23-Dec-2022 9:00 AM EST
UTSW researchers map activity of inherited gene variants linked to prostate cancer
UT Southwestern Medical Center

UT Southwestern researchers have identified the molecular function of 87 inherited genetic variants that affect the risk of prostate cancer, and the majority appear to control the activity of genes located far away from the risk variants themselves.

Newswise: New Study Shows Western Region has Highest Prostate Cancer Mortality Among White Men in U.S.; Black Men Face Highest Prostate Cancer Mortality Overall
19-Dec-2022 11:55 AM EST
New Study Shows Western Region has Highest Prostate Cancer Mortality Among White Men in U.S.; Black Men Face Highest Prostate Cancer Mortality Overall
American Cancer Society (ACS)

New findings led by researchers at the American Cancer Society show the highest mortality rates for prostate cancer in White men were found in the Western region of the United States, including California, despite low incidence rates.

Released: 21-Dec-2022 9:55 AM EST
Tis the season to manage stress: Winter holiday story ideas and expert commentary
Newswise

Here are some of the latest articles that have been added to the Winter Holidays channel on Newswise.

   
Released: 20-Dec-2022 10:05 AM EST
Hispanic and Latino Young Males With Higher Education, Greater Acculturation Are More Likely to Use E-Cigarettes
Rutgers University-New Brunswick

A Rutgers researcher leads study that is among the first to characterize the use of electronic cigarettes among people of Hispanic and Latino backgrounds

   
Released: 20-Dec-2022 9:00 AM EST
New therapies have raised Medicare treatment costs for metastatic prostate cancer
Wolters Kluwer Health: Lippincott

Medicare costs for treatment of metastatic prostate cancer have risen sharply within the last 15 years – reflecting increased use of new medications under Medicare Part D, reports a study in Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 14-Dec-2022 12:30 PM EST
Y chromosome loss may be linked to men's increased risk of severe COVID-19
Uppsala University

Men are at an increased risk of a severe bout of COVID-19 compared to women.

Released: 14-Dec-2022 9:00 AM EST
Genetic testing for prostate cancer increases after introduction of point-of-care program
Wolters Kluwer Health: Lippincott

Some patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing program, pioneered by urologists, could help to close the gap for this underutilized resource, reports a study in Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Scientists identify multiple cell types that may contribute to treatment resistance in prostate cancer
Released: 13-Dec-2022 4:15 PM EST
Scientists identify multiple cell types that may contribute to treatment resistance in prostate cancer
eLife

Researchers have characterised prostate cancer cell dynamics at a single-cell resolution across the timespan of the disease – from its beginning to the point of androgen independence, where the tumour no longer responds to hormone deprivation therapy.

Released: 12-Dec-2022 1:30 PM EST
Medicaid expansion plus PrEP and antivirals could lower HIV transmission in Houston, model projects
Wolters Kluwer Health: Lippincott

Enacting Medicaid expansion in Texas and increasing the use of preventive and antiviral medications could result in a decline of new HIV infections among young Black gay, bisexual, and other men who have sex with men (MSM) in Houston, reports a study in the January issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: UT Southwestern pioneers new minimally invasive treatment for prostate cancer
Released: 9-Dec-2022 12:05 PM EST
UT Southwestern pioneers new minimally invasive treatment for prostate cancer
UT Southwestern Medical Center

UTSW was one of the first medical centers in the U.S. to perform MRI-guided transurethral ultrasound ablation (TULSA) for to treat prostate cancer and recently performed its 100th TULSA procedure.

Newswise: Researchers Study Use of Virtual Reality to Lessen Pain, Anxiety During Vasectomy
Released: 6-Dec-2022 5:05 PM EST
Researchers Study Use of Virtual Reality to Lessen Pain, Anxiety During Vasectomy
University of Miami Health System, Miller School of Medicine

Researchers from the Desai Sethi Urology Institute, part of the University of Miami Miller School of Medicine, have launched a study to determine if wearing virtual reality headsets during in-office vasectomy helps relieve patients of procedure-related pain and anxiety.

Released: 5-Dec-2022 4:05 PM EST
We ain't misbehavin' here. The latest news in Behavioral Science on Newswise
Newswise

Here are some of the latest articles that have been added to the Behavioral Science channel on Newswise, a free source for journalists.

       
Newswise: Direct-to-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone Therapy
2-Dec-2022 12:45 PM EST
Direct-to-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone Therapy
Northwestern Medicine

A new Northwestern Medicine study published in JAMA Internal Medicine found that many of online platforms offering testosterone therapy are not providing care in concordance with the American Urological Association (AUA) and Endocrine Society (ES) guidelines for the safe and effective management of men on testosterone therapy.

5-Dec-2022 8:05 AM EST
MD Anderson Research Highlights: SABCS 2022 Special Edition
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into basic, translational and clinical cancer research from MD Anderson experts. This special edition features breast cancer presentations at the 2022 San Antonio Breast Cancer Symposium (SABCS) focused on the combination of everolimus and hormone therapy, a new driver for brain metastases in inflammatory breast cancer, improving treatment for men with breast cancer, and a new understanding of the importance of HER2 expression for patients with early-stage triple-negative breast cancers.

Newswise: Do women age differently from men?
Released: 1-Dec-2022 7:30 PM EST
Do women age differently from men?
Max Planck Institute for Biology of Ageing

The life expectancy of women is significantly higher than that of men.

Released: 1-Dec-2022 11:55 AM EST
FSU experts weigh in on potential FDA change to blood donation policy
Florida State University

Several national media outlets are reporting that the FDA is considering a new strategy for screening gay and bisexual men to help combat the national blood shortage. Florida State University’s nationally recognized experts are available to provide context to reporters who are working on this story as it develops.

28-Nov-2022 3:40 PM EST
Family History, Gene Variants Put Black Men at Risk for Early Prostate Cancer
Duke Health

A family history of cancer and genetic variants that might be inherited appear to be important risk factors for Black men diagnosed with early-onset prostate cancer, a study involving Duke Health researchers has found.

Not for public release

This news release is embargoed until 28-Nov-2022 7:05 PM EST Released to reporters: 28-Nov-2022 2:15 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 28-Nov-2022 7:05 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded world-cup-soccer-2022-the-medical-perspective
VIDEO
Released: 27-Nov-2022 2:05 PM EST
World Cup Soccer 2022: The Medical Perspective
Cedars-Sinai

Bert Mandelbaum, MD, medical director of the FIFA Medical Center of Excellence, Cedars-Sinai Kerlan-Jobe Institute, and associate chief medical officer of Major League Soccer, has been providing medical care to the U.S men’s national soccer team for nearly three decades.

Newswise: Drug triggers immune cells to attack prostate cancer
Released: 22-Nov-2022 11:05 PM EST
Drug triggers immune cells to attack prostate cancer
Washington University in St. Louis

A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells.

Newswise: UT Southwestern surgeon implants artificial sphincter to improve quality of life after prostate cancer surgery
Released: 21-Nov-2022 9:05 AM EST
UT Southwestern surgeon implants artificial sphincter to improve quality of life after prostate cancer surgery
UT Southwestern Medical Center

Retired firefighter Roger McCurley had an artificial urinary sphincter (AUS) implanted at UT Southwestern’s William P. Clements Jr. University Hospital in Dallas to alleviate urinary leakage following prostate cancer surgery.

Newswise:Video Embedded transcript-and-video-available-live-event-nov-16-researcher-will-discuss-new-screening-tool-to-assess-risk-for-alzheimer-s
VIDEO
Released: 17-Nov-2022 10:55 AM EST
TRANSCRIPT AND VIDEO AVAILABLE: Live Event Nov. 16: Researcher will discuss new screening tool to assess risk for Alzheimer's
Newswise

It is difficult to assess brain health status and risk of cognitive impairment, particularly at the initial evaluation. To address this, researchers have developed the Brain Health Platform to quantify brain health and identify Alzheimer’s disease and related disorders.

       
Released: 16-Nov-2022 12:30 PM EST
Strength gain is associated with training volume in low responders, new study finds
Shibaura Institute of Technology

Exercise plays a significant role in training, rehabilitation, and a healthy lifestyle.

Newswise: Study: Which People With Chronic Pancreatitis Will Develop Diabetes?
Released: 16-Nov-2022 12:05 PM EST
Study: Which People With Chronic Pancreatitis Will Develop Diabetes?
Cedars-Sinai

A new study by Cedars-Sinai investigators describes risk factors that could make it more likely for people who have chronic pancreatitis, an ongoing inflammation of the pancreas, to develop diabetes. The findings are published in Diabetes Care.

Newswise: Hackensack Meridian Mountainside Medical Center becomes first New Jersey hospital approved to treat prostate cancer in adults using Novartis Pluvicto (TM)
Released: 15-Nov-2022 10:00 AM EST
Hackensack Meridian Mountainside Medical Center becomes first New Jersey hospital approved to treat prostate cancer in adults using Novartis Pluvicto (TM)
Hackensack Meridian Health

Mountainside Medical Center is approved to use Pluvicto™, an FDA-approved, targeted radioligand therapy for treatment of metastatic prostate-specific membrane antigen positive castration-resistant prostate cancer. This makes Mountainside the first in the state to offer treatment using Pluvicto™.

Released: 14-Nov-2022 10:05 AM EST
Preventing the next pandemic: Leaders of Pacific Rim Universities meet in Bangkok, Thailand
Newswise

Hosted by Chulalongkorn University the APRU APEC University Leaders' Forum 2022 is the first post-pandemic in-person APEC meeting held to foster high-level dialogue between CEOs, policy leaders, university presidents, and top researchers. This event begins Nov 15 at 9 PM EST.

       
Newswise: UTSW surgeon helps fellow veterans manage wounds to genital areas
Released: 10-Nov-2022 5:05 PM EST
UTSW surgeon helps fellow veterans manage wounds to genital areas
UT Southwestern Medical Center

Many U.S. service members struck by ground explosives during the conflicts in Iraq and Afghanistan suffered genitourinary (GU) injuries to their urinary, genital, and reproductive systems

Released: 10-Nov-2022 11:20 AM EST
Treatment without hormone blockers improves outcomes in solitary prostate cancer metastases
Wolters Kluwer Health: Lippincott

For patients with solitary metastases from prostate cancer, an approach called metastasis-directed therapy (MDT) – focused treatment using surgery or radiation therapy, without androgen deprivation therapy (ADT) – can slow the time to cancer progression, reports a study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: UTHealth Houston researchers analyze cancer discrepancies among young Black men in the South
Released: 10-Nov-2022 10:35 AM EST
UTHealth Houston researchers analyze cancer discrepancies among young Black men in the South
University of Texas Health Science Center at Houston

Research shows that incidences of Kaposi’s sarcoma among people living with HIV have fallen significantly over the past two decades, but a new evaluation of data led by researchers at UTHealth Houston highlights a significant disparity among one particular demographic – young Black men in the American South.

Released: 9-Nov-2022 4:05 PM EST
Study shows heart failure treatment with dapagliflozin consistently benefited both men and women
Brigham and Women’s Hospital

When it comes to heart failure (HF), sex differences are known to impact everything from risk factors to clinical presentation to response to treatment, making sex a key factor to consider in studies of emerging pharmacotherapies.

Released: 9-Nov-2022 3:15 PM EST
Knowledge is power. The latest research on arthritis is right at your fingertips
Newswise

Here are some of the latest articles that have been added to the Arthritis channel on Newswise.

Released: 8-Nov-2022 10:55 AM EST
Hormone discovery could predict long term health of men
University of Nottingham

Researchers have discovered the vital role of a hormone, that develops in men during puberty, in providing an early prediction of whether they could develop certain diseases in later life.

Newswise: Developing Therapies for Treatment-Resistant Prostate Cancer
Released: 2-Nov-2022 5:55 PM EDT
Developing Therapies for Treatment-Resistant Prostate Cancer
Cedars-Sinai

Investigators from Cedars-Sinai Cancer have identified an investigational therapeutic approach that could be effective against treatment-resistant prostate cancer. Results of their Phase II clinical trial, published in the peer-reviewed journal Molecular Therapy, have led to a larger, multicenter trial that will soon be underway.

Released: 2-Nov-2022 1:35 PM EDT
Experts Highlight Link Between Hand Size Difference and COVID-19 Severity
Swansea University

The difference in finger length between a person’s left and right hand may provide vital information about how ill they could get if they contract Covid-19.

Newswise: Genetic Score Predicts Risk of Lethal Prostate Cancer
Released: 31-Oct-2022 2:45 PM EDT
Genetic Score Predicts Risk of Lethal Prostate Cancer
University of California San Diego

Researchers at UC San Diego report that a polygenic hazard score based on 290 genetic variants could be an effective tool for predicting genetic risk of lethal prostate cancer, which kills more than 34,000 men in the U.S. annually.

Released: 28-Oct-2022 12:35 PM EDT
Standard Threshold for Low Testosterone Doesn't Apply to Young Men
Wolters Kluwer Health: Lippincott

The standard cutoff point for low testosterone levels may not be accurate for men in their mid-forties and younger, reports a study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Cecilia Lindestam Arlehamn Wins WHAM Edge Award Funding to Study Sex-Based Differences in Alzheimer's and Parkinson's Diseases
Released: 26-Oct-2022 5:05 PM EDT
Cecilia Lindestam Arlehamn Wins WHAM Edge Award Funding to Study Sex-Based Differences in Alzheimer's and Parkinson's Diseases
La Jolla Institute for Immunology

Cecilia Lindestam Arlehamn, Ph.D., aims to shed light on how sex-based immune system differences may affect the development and progression of these neurodegenerative diseases in men versus women.

Newswise: Study Reveals Pathways for Aggressive Prostate Cancer Subtype
Released: 26-Oct-2022 2:50 PM EDT
Study Reveals Pathways for Aggressive Prostate Cancer Subtype
Vanderbilt University Medical Center

The findings, which are the result of single-cell RNA-sequencing, were published in Nature Communications. The research was conducted in the lab of Paula Hurley, PhD, associate professor of Medicine and Urology. The researchers observed an interplay between the inherent properties of cancer cells and microenvironmental factors that contribute to this aggressive subtype of prostate cancer.

Released: 25-Oct-2022 2:10 PM EDT
The latest news in Opioids, Drug Abuse, and Addiction
Newswise

Here are some of the latest articles that have been added to the Drugs and drug abuse channel.



close
1.66918